Share on LinkedInShare on LinkedIn

ARTICLE · 19 OCTOBER 2015

Australian High Court Rules Gene Patents Unpatentable

BakerHostetler
BakerHostetler
Contributor
BakerHostetler

BakerHostetler

Recognized as an innovator and one of the top firms for client service, BakerHostetler helps...

View firm profile
Explore more from BakerHostetler

Like the United States Supreme Court, the High Court of Australia has determined that Myriad's patents directed to purified and isolated DNA molecules encoding the BRCA genes are unpatentable.

AustraliaIntellectual Property

Like the United States Supreme Court, the High Court of Australia has determined that Myriad's patents directed to purified and isolated DNA molecules encoding the BRCA genes are unpatentable. Indeed, the Australian Court went one step further than the U.S. Court, holding that non-naturally occurring cDNA molecules encoding the genes are also unpatentable.

This decision reverses decades of precedent that recognized the patentability of particular nucleic acid sequences that are isolated from nature and overturned a decision by the Full Federal Court of Australia that had confirmed the patentability of such molecules. The Full Federal Court had held that because the claimed BRCA gene molecules differed from naturally occurring counterparts both structurally and functionally as a result of their isolation, the claims were directed to patentable subject matter. The High Court, however, focused on the information encoded by the molecules, rather than functional and

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from